Antitubercular 2,8-bis(alkylaminomethyl)phenazines

Area of Science:

• Medicinal Chemistry
• Microbiology
• Pharmacology

Background:

• Tuberculosis (TB) remains a significant global health challenge.
• Novel therapeutic agents are needed to combat drug-resistant strains of Mycobacterium tuberculosis.

Purpose of the Study:

• To synthesize and evaluate the antitubercular properties of novel 2,8-bis(alkylaminomethyl)phenazine derivatives.
• To assess the in vitro and in vivo efficacy of these compounds against mycobacterial infections.

Main Methods:

• Synthesis of a series of 2,8-bis(alkylaminomethyl)phenazine compounds.
• In vitro susceptibility testing against Mycobacterium smegmatis ATCC 607.
• In vivo efficacy testing against a lethal Mycobacterium tuberculosis H37Rv infection in a mouse model.

Main Results:

• All synthesized 2,8-bis(alkylaminomethyl)phenazine derivatives exhibited inhibitory activity against Mycobacterium smegmatis in vitro.
• The compound 2,8-Bis(dibutylaminomethyl)phenazine (5c) demonstrated significant therapeutic activity in a mouse model of Mycobacterium tuberculosis infection.

Conclusions:

• 2,8-bis(alkylaminomethyl)phenazines represent a promising class of compounds for the development of new antitubercular drugs.
• Further investigation into the mechanism of action and pharmacokinetic properties of these compounds is warranted.